Related Experiment Video
Updated: Jun 11, 2026
06:43
A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
Autophagy in Alzheimer's disease
Paula I Moreira1, Renato X Santos, Xiongwei Zhu
1University of Coimbra, Coimbra, Portugal.
Expert Review of Neurotherapeutics
|July 1, 2010
Summary
Autophagy, a cellular cleaning process, is linked to Alzheimer's disease (AD) pathogenesis. Clarifying its role in AD is crucial for developing effective neurodegenerative disease therapies.
Area of Science:
- Cellular Biology
- Neuroscience
- Biochemistry
Background:
- Autophagy is a key cellular degradation pathway.
- Mitochondrial dysfunction and amyloid-beta are implicated in Alzheimer's disease (AD) pathogenesis.
- A connection between mitochondrial dysfunction, amyloid-beta, and autophagy in AD has been observed.
Purpose of the Study:
- To elucidate the precise role of autophagy in Alzheimer's disease progression.
- To understand whether autophagy is causative, protective, or a consequence of AD.
- To identify therapeutic targets for neurodegenerative diseases by understanding cellular stress responses.
Main Methods:
- Literature review on autophagy, mitochondrial dysfunction, and amyloid-beta in AD.
- Analysis of existing studies linking these pathways.
- Synthesis of current understanding regarding autophagy's function in AD.
Main Results:
- The exact role of autophagy in Alzheimer's disease (AD) remains unclear.
- Autophagy may be causative, protective, or a downstream effect of AD.
- Understanding autophagy's function is critical for therapeutic development.
Conclusions:
- Further research is needed to define autophagy's specific role in AD.
- Targeting autophagy could offer novel therapeutic strategies for AD.
- Understanding cellular stress responses is vital for treating neurodegenerative disorders.
Related Concept Videos
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...